Vendor Integration: Focus on Customer and Cost Leads Manufacturers to Novel Approach

 

Vendor Integration: Focus on Customer and Cost Leads Manufacturers to Novel Approach

The market shift from oral solid to specialty medications comes with two notable dynamics impacting manufacturers. First, it is increasingly important to provide patient and physician support services, such as reimbursement and patient assistance programs. Second, the FDA has imposed more stringent mandates on manufacturers to ensure the safety of approved products, primarily consisting of risk evaluation and mitigation strategies (REMS) and other post-launch surveillance requirements.